Skip to content
20-F/A

Annual Report (Foreign)

ZEALAND PHARMA A/S

0001104659-22-042831

← back to feed
Filed
Apr 5, 2022 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2021 · Dec 31, 2021 43.19M sh
Shares Diluted FY 2021 · Dec 31, 2020 38.43M sh
Shares Diluted FY 2021 · Dec 31, 2019 33.87M sh
Operating Cash Flow FY 2021 · Dec 31, 2021 −1.21B
Operating Cash Flow FY 2021 · Dec 31, 2020 −688.72M
Operating Cash Flow FY 2021 · Dec 31, 2019 −409.46M
Cash And Equivalents FY 2021 · Dec 31, 2021 1.13B
Cash And Equivalents FY 2021 · Dec 31, 2020 960.22M
Cash And Equivalents FY 2021 · Dec 31, 2019 1.08B
Cash And Equivalents FY 2021 · Dec 31, 2018 860.64M
Stockholders Equity FY 2021 · Dec 31, 2021 927.8M
Stockholders Equity FY 2021 · Dec 31, 2020 1.23B
Stockholders Equity FY 2021 · Dec 31, 2019 1.24B
Stockholders Equity FY 2021 · Dec 31, 2018 1.12B
Current Liabilities FY 2021 · Dec 31, 2021 334.32M
Current Liabilities FY 2021 · Dec 31, 2020 355.26M
Total Liabilities FY 2021 · Dec 31, 2021 1.14B
Total Liabilities FY 2021 · Dec 31, 2020 532.64M
Current Assets FY 2021 · Dec 31, 2021 1.72B
Current Assets FY 2021 · Dec 31, 2020 1.42B
Total Assets FY 2021 · Dec 31, 2021 2.07B
Total Assets FY 2021 · Dec 31, 2020 1.76B
Eps Diluted FY 2021 · Dec 31, 2021 −23.75
Eps Diluted FY 2021 · Dec 31, 2020 −22.07
Eps Diluted FY 2021 · Dec 31, 2019 −16.91
Eps Basic FY 2021 · Dec 31, 2021 −23.75
Eps Basic FY 2021 · Dec 31, 2020 −22.07
Eps Basic FY 2021 · Dec 31, 2019 −16.91
Rd Expense FY 2021 · Dec 31, 2021 588.45M
Rd Expense FY 2021 · Dec 31, 2020 604.08M
Rd Expense FY 2021 · Dec 31, 2019 561.42M
Net Income FY 2021 · Dec 31, 2021 −1.02B
Net Income FY 2021 · Dec 31, 2020 −846.73M
Net Income FY 2021 · Dec 31, 2019 −571.54M
Operating Income FY 2021 · Dec 31, 2021 −1.05B
Operating Income FY 2021 · Dec 31, 2020 −792.36M
Operating Income FY 2021 · Dec 31, 2019 −587.94M
Gross Profit FY 2021 · Dec 31, 2021 173.75M
Gross Profit FY 2021 · Dec 31, 2020 262.75M
Gross Profit FY 2021 · Dec 31, 2019 40.92M
Revenue FY 2021 · Dec 31, 2021 292.57M
Revenue FY 2021 · Dec 31, 2020 353.31M
Revenue FY 2021 · Dec 31, 2019 41.33M